ResearcherCapital Medical UniversityActive in the last 2 years

Yanbin Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6292-8352; OpenAlex author ID A5100680383. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis. Last author DOI 10.1186/s12957-024-03464-9 ↗
Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adeno… Co-author DOI 10.1038/s41392-020-00346-w ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guojun Yan · 1 shared paper, 2024 · strength 0.31
- Paper Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with p… DOI 10.1186/s12957-024-03464-9 ↗
Qiang Sun · 1 shared paper, 2020 · strength 0.11
- Paper Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patien… DOI 10.1038/s41392-020-00346-w ↗
Hongyan Huang · 1 shared paper, 2020 · strength 0.11
- Paper Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patien… DOI 10.1038/s41392-020-00346-w ↗
Meifang He · 1 shared paper, 2020 · strength 0.11
- Paper Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patien… DOI 10.1038/s41392-020-00346-w ↗
Wen Li Ma · 1 shared paper, 2020 · strength 0.11
- Paper Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patien… DOI 10.1038/s41392-020-00346-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.